These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1062 related items for PubMed ID: 15032383

  • 21. Immunomodulation with minocycline rescues retinal degeneration in juvenile neuronal ceroid lipofuscinosis mice highly susceptible to light damage.
    Dannhausen K, Möhle C, Langmann T.
    Dis Model Mech; 2018 Sep 05; 11(9):. PubMed ID: 30042155
    [Abstract] [Full Text] [Related]

  • 22. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Bosch ME, Aldrich A, Fallet R, Odvody J, Burkovetskaya M, Schuberth K, Fitzgerald JA, Foust KD, Kielian T.
    J Neurosci; 2016 Sep 14; 36(37):9669-82. PubMed ID: 27629717
    [Abstract] [Full Text] [Related]

  • 23. Neuronal ceroid lipofuscinoses: research update.
    Wisniewski KE, Kida E, Connell F, Zhong N.
    Neurol Sci; 2000 Sep 14; 21(3 Suppl):S49-56. PubMed ID: 11073228
    [Abstract] [Full Text] [Related]

  • 24. Carrier detection of Batten disease (juvenile neuronal ceroid-lipofuscinosis).
    Taschner PE, de Vos N, Post JG, Meijers-Heijboer EJ, Hofman I, Loonen MC, Pinckers AJ, Bleeker-Wagemakers EM, Gardiner RM, Breuning MH.
    Am J Med Genet; 1995 Jun 05; 57(2):333-7. PubMed ID: 7668358
    [Abstract] [Full Text] [Related]

  • 25. Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis.
    Gomez-Giro G, Arias-Fuenzalida J, Jarazo J, Zeuschner D, Ali M, Possemis N, Bolognin S, Halder R, Jäger C, Kuper WFE, van Hasselt PM, Zaehres H, Del Sol A, van der Putten H, Schöler HR, Schwamborn JC.
    Acta Neuropathol Commun; 2019 Dec 30; 7(1):222. PubMed ID: 31888773
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Gene symbol: CLN3. Disease: juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR, Pearce DA, Rothberg PG.
    Hum Genet; 2005 Feb 30; 116(3):236. PubMed ID: 15818814
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Developmental impairments of select neurotransmitter systems in brains of Cln3(Deltaex7/8) knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis.
    Herrmann P, Druckrey-Fiskaaen C, Kouznetsova E, Heinitz K, Bigl M, Cotman SL, Schliebs R.
    J Neurosci Res; 2008 Jun 30; 86(8):1857-70. PubMed ID: 18265413
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A novel mutation af Cln3 associated with delayed-classic juvenile ceroid lipofuscinois and autophagic vacuolar myopathy.
    Licchetta L, Bisulli F, Fietz M, Valentino ML, Morbin M, Mostacci B, Oliver KL, Berkovic SF, Tinuper P.
    Eur J Med Genet; 2015 Oct 30; 58(10):540-4. PubMed ID: 26360874
    [Abstract] [Full Text] [Related]

  • 33. First case of genetically confirmed CLN3 disease in Chinese with cDNA sequencing revealing pathogenicity of a novel splice site variant.
    Lau NKC, Ching CK, Lee HHC, Chak WKM, Kwan Shing N, Hanchard NA, Mak CM.
    Clin Chim Acta; 2018 Nov 30; 486():151-155. PubMed ID: 30053402
    [Abstract] [Full Text] [Related]

  • 34. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.
    Kwon JM, Rothberg PG, Leman AR, Weimer JM, Mink JW, Pearce DA.
    Neurosci Lett; 2005 Oct 21; 387(2):111-4. PubMed ID: 16087292
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Variant late infantile neuronal ceroid lipofuscinosis because of CLN1 mutations.
    Simonati A, Tessa A, Bernardina BD, Biancheri R, Veneselli E, Tozzi G, Bonsignore M, Grosso S, Piemonte F, Santorelli FM.
    Pediatr Neurol; 2009 Apr 21; 40(4):271-6. PubMed ID: 19302939
    [Abstract] [Full Text] [Related]

  • 37. Further Characterization of the Predominant Inner Retinal Degeneration of Aging Cln3 Δex7/8 Knock-In Mice.
    Volz C, Mirza M, Langmann T, Jägle H.
    Adv Exp Med Biol; 2018 Apr 21; 1074():403-411. PubMed ID: 29721970
    [Abstract] [Full Text] [Related]

  • 38. Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis.
    Lauronen L, Munroe PB, Järvelä I, Autti T, Mitchison HM, O'Rawe AM, Gardiner RM, Mole SE, Puranen J, Häkkinen AM, Kirveskari E, Santavuori P.
    Neurology; 1999 Jan 15; 52(2):360-5. PubMed ID: 9932957
    [Abstract] [Full Text] [Related]

  • 39. A recessive CLN3 variant is responsible for delayed-onset retinal degeneration in Hereford cattle.
    Reith RR, Batt MC, Fuller AM, Meekins JM, Diehl KA, Zhou Y, Bedwell PS, Ward JA, Sanders SK, Petersen JL, Steffen DJ.
    J Vet Diagn Invest; 2024 May 15; 36(3):438-446. PubMed ID: 38516801
    [Abstract] [Full Text] [Related]

  • 40. Homogeneous polymerase chain reaction nucleobase quenching assay to detect the 1-kbp deletion in CLN3 that causes Batten disease.
    Rothberg PG, Ramirez-Montealegre D, Frazier SD, Pearce DA.
    J Mol Diagn; 2004 Aug 15; 6(3):260-3. PubMed ID: 15269304
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.